Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DanCann Pharma A/S appoints Helle Bjerregaard as Head of Quality

COPENHAGEN, Denmark, 16 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) is pleased to announce the employment of Helle Bjerregaard. Helle Bjerregaard has been appointed as Head of Quality (HOQ) at DanCann Pharma A/S.Helle Bjerregaard joins the DanCann Pharma team as the company’s Head of Quality. She is a certified Quality Management professional and will oversee implementing relevant quality systems according to global standards such as GMP and ISO 9001. Helle Bjerregaard has a proven track record within Quality Management and joins DanCann Pharma from a

Report from the Annual General Meeting of Risk Intelligence A/S

Risk Intelligence A/S ("Risk Intelligence") held on 16 April 2021, the Annual General Meeting. Below are the minutes of the meeting.Today, Friday 16 April 2021 at 10 am, the annual general meeting in Risk Intelligence A/S was held via Zoom. The following was conducted, adopted and recorded according to the agenda sent out to the shareholders on 25 March 2021: 1. Election of chairman of the meeting                  Attorney at law Sune Westrup was elected as chairman of the meeting.                 The chairman of the meeting noted that the general meeting had been lawfully

Orkla ASA – Issuance of Commercial Paper (6 months)

Orkla ASA has issued a commercial paper of NOK 500,000,000.Start date:                   21 April 2021 Maturity:                     21 October 2021 Coupon:                      3 month NIBOR + 10 bps. Organised by:             Nordea Markets           Orkla ASA Oslo, 16 April 2021   Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

CFO Robert Berglund to resign from Musti Group

Musti Group plc                        Stock Exchange Release    16 April 2021 at 12.30 p.m. CFO Robert Berglund to resign from Musti Group Robert Berglund, CFO and member of the Management Team of Musti Group, has announced that he will resign from the company. The resignation will take effect in October 2021. The company has commenced a search to recruit a new CFO. CEO David Rönnberg: “Robert has had a significant role in developing the company to what it is today. I want to sincerely thank him for his efforts towards the company and for a great cooperation and wish him all

RNB RETAIL AND BRANDS AB (PUBL) makes a partial repayment of SEK 158 678 000 on its outstanding senior bond

RNB RETAIL AND BRANDS AB (publ) (the "Company") today announces that it makes a partial repayment in the amount of SEK 158 678 000 on the notes with ISIN SE0010625830 (the "Notes")(the "Partial Repayment"). The Partial Repayment is made pursuant to clause 11.6 (Mandatory partial repayment due to the Permitted Disposal) of the terms and conditions of the Notes. The Partial Repayment is made following the Company's disposal of all shares in Polarn O. Pyret AB. The record date for the Partial Repayment is 27 April 2021 and the Partial Repayment will take place on 4 May 2021. For

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS (tobe sent to therelevantissuer and to theFCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

NCC to develop KY Building in Helsinki into modern office premises

NCC has acquired and is now commencing renovation of the illustrious and centrally located KY Building in Helsinki, Finland. The property, which is the former students’ union building of Helsinki School of Economics, will be renovated and converted into a modern, sustainable and multifunctional office block. Photo: Julio H. Orduña Sánchez, OlaDesign NCC Property Development acquired the property from KY Foundation, a student organization at the School of Business of Aalto University, in December 2020. The property is situated in central Helsinki and the project has an area of

Read original

Conference call in connection with interim report January-March 2021

Analysts, investors and the media are invited to a conference call in connection with the publication of the interim report on Wednesday, 12 May at 8.45 CET. The presentation will be held in English. To attend the conference call please register using the link below. After registration you will receive dial in numbers and pin code.Please register here  The presentation material will be published on balder.se   For further information, please

PowerCell Sweden presents comprehensive product portfolio optimized for off-road electrification

PowerCell Sweden is now presenting a complete product portfolio for hydrogen electrification for the off-road segment, enabling a transition away from diesel engine-based powertrains. The product portfolio comprises complete fuel cell systems under the PowerCellution brand with an output from 60 kW up to megawatt installations.“Our industrialized fuel cell systems offer customers minimized technical risk, minimized time-to-market and minimized investment costs in the unavoidable transition to zero-emissions solutions. With the industrialized base products, we can offer customized solutions

NPRO: Annual General Meeting held in Norwegian Property ASA

Norwegian Property ASA has today held its annual general meeting. All matters were resolved as proposed in the notice. The board of directors’ proposal to the annual accounts and the annual report for Norwegian Property ASA for the financial year 2020 was approved by the general meeting. The annual general meeting re-elected Merete Haugli as Chair, Bjørn Henningsen as Deputy Chair, Kathrine Astrup Fredriksen, Cecilie Astrup Fredriksen, Lars Erich Nilsen, Carl Erik Krefting and Anders Buchardt as ordinary board members for a period until the annual general meeting in 2022. The

Report from the Extraordinary General Meeting 2021 in Elekta

SWEDEN, April 16, 2021 – Elekta AB (publ) (EKTA-B.ST) has held an Extraordinary General Meeting on Friday 16 April 2021. Due to Covid-19, the Meeting was conducted by advance postal vote, without the physical attendance of shareholders, representatives or third parties.A summary of the resolutions taken by the Meeting follows. For complete details concerning all resolutions, please see the Meeting documents that are available on the Company’s website, www.elekta.com. Extra dividend and record dateThe Meeting resolved, in accordance with the Board of Directors’ proposal, on an extra

Vator Securities: Unlocking US reimbursement – the share price catalyst during 2021

SciBase is delivering as we expected, and the share price is closing in on our target price. Recent news flow confirms the Nevisense EIS-technology’s potential for skin barrier assessment applications – an upside to both our and the market’s valuation of the company. The apparent tangible driver of the share price for the coming 12 months, however, is unlocking US reimbursement (Medicare) where the US company DermTech offers a clear blueprint. DermTech (DMTK: Nasdaq US) is a close peer to SciBase, commercializing a molecular assay for melanoma detection in the US. DermTech generated

Dignitana publishes April newsletter

Dignitana AB today publishes the April newsletter featuring the recent Dignitana presentation at the Life Science Capital Markets Days and a DigniCap patient video. To read the newsletter click here  or visit Dignitana.com .The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email, subscribe here 

Cereno Scientific sets study timeline of upcoming Phase II study with CS1 in rare disease PAH to start September 2021

Cereno Scientific today announced that the timelines for the upcoming clinical Phase II with drug candidate CS1 has been set following the signing of the final agreements with clinical research organization Worldwide Clinical Trials. The preparatory work together with Worldwide has proceeded since a letter of intent (LOI) was signed earlier this year, resulting in a study timeline for the Phase II study with CS1 in PAH anchored with relevant parties. If the study timeline is followed according to plan, the first patient will start in September 2021 with study results expected in H2 2022.“

Invitation to AAK’s presentation of the first quarter 2021 on April 23

In connection with the release of AAK’s Interim report for the first quarter 2021, we invite you to a press and analyst conference to be held on Friday, April 23, 2021, at 1 p.m. CET. The conference will be chaired by Johan Westman, President and CEO, and the presentation will be held in English. The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only. To follow the conference by phone, please use one of the following numbers:SE: +46 8 566 426 95DK: +45 7872 3250UK: +44 3333 009 263US: +1 833 249 8403 To follow the

Talkpool AG invites its shareholders to attend the Annual General Meeting

Invitation to the Annual General Meeting of Talkpool AG on the 6[th] of May 2021Talkpool AG invites its shareholders to remotely attend the Annual General Meeting via video on the 6[th] of May 2021 at 10:00. The meeting will be streamed from Talkpool’s offices at Gäuggelistrasse 7, 7000 Chur, Switzerland. Shareholders should beforehand instruct the independent representative about voting preferences.This is a summary. The full invitation and registration document is available from the 16[th] of April 2021 on Talkpool’s website https://talkpool.com/financial-calendar/#investor

EQL chooses to postpone the list change to Nasdaq Stockholm

EQL Pharma revises the schedule for the planned list change from Spotlight Stock Market to Nasdaq Stockholm's main list, with the goal that the list change will be carried out after the summer of 2021 instead of the first quarter of the financial year 2021/22 as previously communicated.The decision to postpone the list change is due to the prioritization of the acquisition of seven product licenses in Denmark during the spring and winter, which was announced on March 15, 2021. Through that prioritization, the company needed to move resources from the listing process to the acquisition. This

New analysis shows significant long-term potential in Brighter’s various offers and the company’s share price

Brighter AB [publ],  today announced that Aktiespararna has provided an updated company analysis.  Included in Aktiespararna’s update is an analysis of the key milestones that Brighter has completed across the company’s three product lines: Actiste®, Camanio and Nectarine Health.  Brighter signed distribution agreements in three new markets: Ghana, Nigeria and Qatar for Actiste and received market approvals for Actiste® and Actiste® Mini in various regions. The analysis continues to discuss the establishment of a framework agreement with Sweden's Municipalities and Regions for Camanio

Two recently published papers mark a milestone for Attana which now has enabled 140 scientific publications

Two new scientific publications featuring Attana’s analytical instruments have recently been published in peer reviewed journals including the highly regarded Sensors and Actuators B: Chemical as well as Plos One. The two new publications mark a milestone for Attana, which has to date enabled 140 publications.Publication 1: Direct Attachment of suspension cells to PDA surface and its application in suspension-cell QCM biosensor The study investigated the attachment property of suspension cells on the Mussel-inspired polydopamine (PDA) surface. The study was based upon a PDA-based

Notice of annual general meeting in Nordic Paper Holding AB (publ)

The shareholders of Nordic Paper Holding AB (publ), Reg. No. 556914-1913, with its registered office in Karlstad municipality in Värmland county, (the “Company” or “Nordic Paper”), are hereby invited to the annual general meeting on Thursday 20 May 2021.Due to the extraordinary situation resulting from the covid-19 pandemic, Nordic Paper’s annual general meeting will be carried out through mandatory advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the annual general

There are no items matching the current filter
There are no more items matching the current filter
Back to top